全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

基于“五脏元真通畅”探析肌少症辨治思路
Analyzing the Diagnosis and Treatment Ideas of Sarcopenia Based on the “Theory of Unlocked-Circulation of Five Zang-Organs”

DOI: 10.12677/jcpm.2024.34206, PP. 1448-1456

Keywords: 肌少症,痿证,五脏元真通畅,气血津液,脏腑辨证
Sarcopenia
, Atrophy Syndrome, Unlocked-Circulation of Five Zang-Organs Essence, Qi Blood and Fluids, Syndrome Differentiation of Viscera

Full-Text   Cite this paper   Add to My Lib

Abstract:

肌肉减少症是一类复杂的临床综合征,目前尚无确切的中医病名,笔者从病症证角度将其辨为痿证一类。其病因病机虽繁杂多变,但有关肌少症的证、因、脉、治不外乎五脏功能失调,病现于筋骨肌肉,但根植于五脏。故临床辨治是基于“五脏元真通畅”理论,运用系统变易思维整体调治,把握脏腑动态观。以元真通畅为顺,气血津液中和为期,依其好恶,平其盈亏,使脏腑各司其职,气机周流无碍,血脉津液和达,则脏安痿平。
Sarcopenia is a complex clinical syndrome, and there is no exact Chinese medicine name, the author from the point of view of the disease certificate will be identified as a class of impotence. The etiology and pathogenesis of the disease is complex and varied, but there are evidence, causes, veins, and treatments for sarcopenia as a dysfunction of the five viscera, the disease is now in the sinews and bones of the muscles, but rooted in the five viscera. So the clinical diagnosis and treatment need to be based on the “theory of unlocked-circulation of five zang-organs” essence, the use of the system of variable thinking overall treatment, grasp the dynamic view of the internal organs. To take five zang-organs essence fluency, and achieve the desired harmonization of qi, blood and fluids, according to their likes and dislikes, and balancing their strengths and weaknesses, so that the internal organs in their respective roles, the flow of qi is unobstructed, the blood and fluids are harmonized, only in this way can the five organs be at peace and impotence be cured.

References

[1]  Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., et al. (2018) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing, 48, 16-31.
https://doi.org/10.1093/ageing/afy169
[2]  Lang, T., Streeper, T., Cawthon, P., Baldwin, K., Taaffe, D.R. and Harris, T.B. (2009) Sarcopenia: Etiology, Clinical Consequences, Intervention, and Assessment. Osteoporosis International, 21, 543-559.
https://doi.org/10.1007/s00198-009-1059-y
[3]  Chen, L., Woo, J., Assantachai, P., Auyeung, T., Chou, M., Iijima, K., et al. (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21, 300-307.e2.
https://doi.org/10.1016/j.jamda.2019.12.012
[4]  张伯礼, 吴勉华. 中医内科学[M]. 北京: 中国中医药出版社, 2017: 400-406.
[5]  田代华. 黄帝内经素问[M]. 北京: 人民卫生出版社, 2005: 87-88.
[6]  张龙, 刘海涛, 田建辉. “五脏元真通畅”与“通以治癌” [J]. 上海中医药杂志, 2023, 57(4): 13-17.
[7]  黄梦文, 高昭, 曾静, 等. 基于“五脏元真通畅”论调气机、和血脉辨治心悸思路[J]. 中国中医基础医学杂志, 2023, 29(11): 1938-1941.
[8]  刘芳, 周胜强, 王琦, 等. 国医大师刘祖贻杂病辨治新论——“调畅元真, 气阳主用” [J]. 中医杂志, 2020, 61: 1225-1229.
[9]  张向玉. 《黄帝内经》“精”理论及其临床价值研究[D]: [博士学位论文]. 兰州: 甘肃中医药大学, 2023.
[10]  灵枢经[M]. 北京: 人民卫生出版社, 1956.
[11]  杨上善. 黄帝内经太素新校正[M]. 北京: 学苑出版社, 2006: 535.
[12]  Sieber, C.C. (2019) Malnutrition and Sarcopenia. Aging Clinical and Experimental Research, 31, 793-798.
https://doi.org/10.1007/s40520-019-01170-1
[13]  Lutski, M., Weinstein, G., Tanne, D. and Goldbourt, U. (2020) Overweight, Obesity, and Late-Life Sarcopenia among Men with Cardiovascular Disease, Israel. Preventing Chronic Disease, 17, Article ID: 200167.
https://doi.org/10.5888/pcd17.200167
[14]  胡勇, 张惜燕, 邢玉瑞, 等. 叶天士辨治痿证学术思想特色探微[J]. 吉林中医药, 2022, 42(6): 633-636.
[15]  Narici, M.V. and de Boer, M.D. (2010) Disuse of the Musculo-Skeletal System in Space and on Earth. European Journal of Applied Physiology, 111, 403-420.
https://doi.org/10.1007/s00421-010-1556-x
[16]  Chen, Y.Y., Wen, C.Y. and Jiao, Q.H. (2021) Effect of Bu Zhong Yi Qi Tang with Addition and Subtraction on Inflammatory Factors in Elderly Patients with Sarcopenia. China Medicine and Pharmacy, 11, 13-16.
[17]  Guo, C., Ma, Y., Liu, S., Zhu, R., Xu, X., Li, Z., et al. (2022) Traditional Chinese Medicine and Sarcopenia: A Systematic Review. Frontiers in Aging Neuroscience, 14, Article ID: 872233.
https://doi.org/10.3389/fnagi.2022.872233
[18]  Liu, Y., Weng, W., Gao, R. and Liu, Y. (2019) New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 4598167.
https://doi.org/10.1155/2019/4598167
[19]  劳泽辉, 黄智斌, 彭俊祥. 从“土克水”角度认识“骨痿” [J]. 中国骨质疏松杂志, 2021, 27(4): 609-612+624.
[20]  Li, Z., Tong, X., Ma, Y., Bao, T. and Yue, J. (2022) Prevalence of Depression in Patients with Sarcopenia and Correlation between the Two Diseases: Systematic Review and Meta‐Analysis. Journal of Cachexia, Sarcopenia and Muscle, 13, 128-144.
https://doi.org/10.1002/jcsm.12908
[21]  Cabanas‐Sánchez, V., Esteban‐Cornejo, I., Parra‐Soto, S., Petermann‐Rocha, F., Gray, S.R., Rodríguez‐Artalejo, F., et al. (2022) Muscle Strength and Incidence of Depression and Anxiety: Findings from the UK Biobank Prospective Cohort Study. Journal of Cachexia, Sarcopenia and Muscle, 13, 1983-1994.
https://doi.org/10.1002/jcsm.12963
[22]  Inoue, T., Ueshima, J., Kawase, F., Kobayashi, H., Nagano, A., Murotani, K., et al. (2022) Trajectories of the Prevalence of Sarcopenia in the Pre-and Post-Stroke Periods: A Systematic Review. Nutrients, 15, Article No. 113.
https://doi.org/10.3390/nu15010113
[23]  俞柏翎, 李娟, 叶茂盛, 等. 肌肉减少症的中医病名探讨[J]. 中华中医药杂志, 2022, 37(10): 6105-6107.
[24]  Henin, G., Lanthier, N. and Dahlqvist, G. (2022) Pathophysiological Changes of the Liver-Muscle Axis in End-Stage Liver Disease: What Is the Right Target? Acta Gastro Enterologica Belgica, 85, 611-624.
https://doi.org/10.51821/85.4.10899
[25]  Roh, E., Hwang, S.Y., Yoo, H.J., Baik, S.H., Lee, J., Son, S.J., et al. (2021) Impact of Non-Alcoholic Fatty Liver Disease on the Risk of Sarcopenia: A Nationwide Multicenter Prospective Study. Hepatology International, 16, 545-554.
https://doi.org/10.1007/s12072-021-10258-8
[26]  廖丽姗, 于秀辰. 张锡纯痹痿同治经验探析[J]. 现代中医临床, 2022, 29(5): 60-63.
[27]  张雅妮, 胡华, 刘佳, 等. 《杂病源流犀烛》论治痿证探析[J]. 中医药临床杂志, 2023, 35(7): 1294-1297.
[28]  Sepúlveda‐Loyola, W., Osadnik, C., Phu, S., Morita, A.A., Duque, G. and Probst, V.S. (2020) Diagnosis, Prevalence, and Clinical Impact of Sarcopenia in COPD: A Systematic Review and Meta‐Analysis. Journal of Cachexia, Sarcopenia and Muscle, 11, 1164-1176.
https://doi.org/10.1002/jcsm.12600
[29]  Wu, X., Li, X., Xu, M., Zhang, Z., He, L. and Li, Y. (2021) Sarcopenia Prevalence and Associated Factors among Older Chinese Population: Findings from the China Health and Retirement Longitudinal Study. PLOS ONE, 16, e0247617.
https://doi.org/10.1371/journal.pone.0247617
[30]  Nikkuni, E., Hirama, T., Hayasaka, K., Kumata, S., Kotan, S., Watanabe, Y., et al. (2021) Recovery of Physical Function in Lung Transplant Recipients with Sarcopenia. BMC Pulmonary Medicine, 21, Article No. 124.
https://doi.org/10.1186/s12890-021-01442-5
[31]  李羲子, 金子开, 高思远等. 金元四大家痿证诊疗思路探微[J]. 陕西中医药大学学报, 2021, 44(4): 61-66.
[32]  贾秋颖. 治痿未必独取阳明——国医大师熊继柏教授从《黄帝内经》理论出发治疗痿证思路探讨[J]. 成都中医药大学学报, 2021, 44(1): 5-7.
[33]  Papadopoulou, S. (2020) Sarcopenia: A Contemporary Health Problem among Older Adult Populations. Nutrients, 12, Article No. 1293.
https://doi.org/10.3390/nu12051293
[34]  Dodds, R., Denison, H.J., Ntani, G., Cooper, R., Cooper, C., Sayer, A.A., et al. (2012) Birth Weight and Muscle Strength: A Systematic Review and Meta-Analysis. The Journal of Nutrition, Health and Aging, 16, 609-615.
https://doi.org/10.1007/s12603-012-0053-9
[35]  Wilkinson, T.J., Miksza, J., Yates, T., Lightfoot, C.J., Baker, L.A., Watson, E.L., et al. (2021) Association of Sarcopenia with Mortality and End‐Stage Renal Disease in Those with Chronic Kidney Disease: A UK Biobank Study. Journal of Cachexia, Sarcopenia and Muscle, 12, 586-598.
https://doi.org/10.1002/jcsm.12705
[36]  Cheng, L., Sit, J.W.H., Chan, H.Y.L., Choi, K.C., Cheung, R.K.Y., Wong, M.M.H., et al. (2021) Sarcopenia Risk and Associated Factors among Chinese Community-Dwelling Older Adults Living Alone. Scientific Reports, 11, Article No. 22219.
https://doi.org/10.1038/s41598-021-01614-7
[37]  陈树东, 林方政, 田瑞敏, 等. 基于“肌肉濡渍”探讨肌少症的中医发病机制及防治措施[J]. 中医正骨, 2023, 35(9): 71-75.
[38]  张思雅, 胡滟琦, 刘晓龙, 等. 新安医家孙一奎辨治痿证特色探微[J]. 环球中医药, 2022, 15(11): 2108-2111.
[39]  余虹, 敬进华, 古再努尔·依力亚尔, 等. 基于“肝脾肾同调”浅析肝硬化肌少症的辨治思路[J]. 中医研究, 2023, 36(9): 12-17.
[40]  Gao, Q., Hu, K., Yan, C., Zhao, B., Mei, F., Chen, F., et al. (2021) Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Nutrients, 13, Article No. 4291.
https://doi.org/10.3390/nu13124291
[41]  Hwang, J. and Park, S. (2022) Gender-Specific Risk Factors and Prevalence for Sarcopenia among Community-Dwelling Young-Old Adults. International Journal of Environmental Research and Public Health, 19, Article No. 7232.
https://doi.org/10.3390/ijerph19127232
[42]  Beckett, N.S., Peters, R., Fletcher, A.E., Staessen, J.A., Liu, L., Dumitrascu, D., et al. (2008) Treatment of Hypertension in Patients 80 Years of Age or Older. New England Journal of Medicine, 358, 1887-1898.
https://doi.org/10.1056/nejmoa0801369
[43]  Silventoinen, K., Magnusson, P.K.E., Tynelius, P., Batty, G.D. and Rasmussen, F. (2008) Association of Body Size and Muscle Strength with Incidence of Coronary Heart Disease and Cerebrovascular Diseases: A Population-Based Cohort Study of One Million Swedish Men. International Journal of Epidemiology, 38, 110-118.
https://doi.org/10.1093/ije/dyn231
[44]  Mancin, L., Wu, G.D. and Paoli, A. (2023) Gut microbiota-Bile Acid-Skeletal Muscle Axis. Trends in Microbiology, 31, 254-269.
https://doi.org/10.1016/j.tim.2022.10.003
[45]  Liu, C., Cheung, W., Li, J., Chow, S.K., Yu, J., Wong, S.H., et al. (2021) Understanding the Gut Microbiota and Sarcopenia: A Systematic Review. Journal of Cachexia, Sarcopenia and Muscle, 12, 1393-1407.
https://doi.org/10.1002/jcsm.12784
[46]  张淑, 袁明, 吴士文. 血府逐瘀胶囊对模拟失重下骨骼肌萎缩的防护作用[J]. 中华灾害救援医学, 2016, 4(11): 618-623.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133